Cold Water Immersion and Recovery
CWI
Cold Water Immersion as a Strategy to Promote Post-exercise Recovery in Healthy Young Men
1 other identifier
interventional
12
1 country
1
Brief Summary
Cold-water immersion (CWI) is a frequently applied strategy to accelerate post-exercise recovery in both recreational as well as professional athletes. However, the effect of repeated post-exercise CWI on other recovery strategies remains unclear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 3, 2015
CompletedFirst Posted
Study publicly available on registry
November 4, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedAugust 2, 2016
August 1, 2016
6 months
November 3, 2015
August 1, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Muscle protein synthesis (expressed as fractional synthetic rate (FSR in %/h)
2 weeks
Secondary Outcomes (2)
Muscle temperature (expressed as degrees celsius)
1 day
Glycogen concentration (expressed as micromol glycosol units*g dry wt)
1 day
Study Arms (1)
Water temperature
EXPERIMENTALInterventions
Different temperatures of cold water immersion will be assessed
Eligibility Criteria
You may qualify if:
- Males
- Aged between 18-35 years
- Healthy, recreationally active
- BMI \< 25 kg/m2
- The ability to comply with the protocol (i.e. the set-up for the CWI is designed for subjects that are at least 1.70 m or taller).
You may not qualify if:
- Smoking
- Allergies to milk proteins (whey or casein)
- Female
- Arthritic conditions
- A history of neuromuscular problems
- Recent (\<1 y) participation in amino acid tracer studies
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
- Individuals with GI diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University
Maastricht, Limburg, 6200 MD, Netherlands
Related Publications (1)
Gorissen SHM, Trommelen J, Kouw IWK, Holwerda AM, Pennings B, Groen BBL, Wall BT, Churchward-Venne TA, Horstman AMH, Koopman R, Burd NA, Fuchs CJ, Dirks ML, Res PT, Senden JMG, Steijns JMJM, de Groot LCPGM, Verdijk LB, van Loon LJC. Protein Type, Protein Dose, and Age Modulate Dietary Protein Digestion and Phenylalanine Absorption Kinetics and Plasma Phenylalanine Availability in Humans. J Nutr. 2020 Aug 1;150(8):2041-2050. doi: 10.1093/jn/nxaa024.
PMID: 32069356DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 3, 2015
First Posted
November 4, 2015
Study Start
November 1, 2015
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
August 2, 2016
Record last verified: 2016-08